SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fausto Petrelli, Andrea Coinu, Mary Cabiddu, Mara Ghilardi, Ivano Vavassori, Sandro Barni, Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis, European Urology, 2014, 65, 2, 350

    CrossRef

  2. 2
    Eric S. Winer, Howard Safran, Boguslawa Karaszewska, Donald A. Richards, Lee Hartner, Frederic Forget, Rodryg Ramlau, Kirushna Kumar, Bhabita Mayer, Brendan M. Johnson, Conrad A. Messam, Yasser Mostafa Kamel, Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study, Cancer Medicine, 2014, 3, 4
  3. 3
    Kirk A. Keegan, Harras B. Zaid, Sanjay G. Patel, Sam S. Chang, Increasing Utilization of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer in the United States, Current Urology Reports, 2014, 15, 4

    CrossRef

  4. 4
    Jong Chul Park, Deborah E. Citrin, Piyush K. Agarwal, Andrea B. Apolo, Multimodal management of muscle-invasive bladder cancer, Current Problems in Cancer, 2014, 38, 3, 80

    CrossRef

  5. 5
    Matthew Mossanen, Franklin Lee, Heather Cheng, William Harris, Jaideep Shenoi, Song Zhao, Junfeng Wang, Thomas Champion, Jason Izard, John L. Gore, Michael P. Porter, Evan Y. Yu, Jonathan L. Wright, Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder, Clinical Genitourinary Cancer, 2014, 12, 3, 210

    CrossRef

  6. 6
    Estrella M. Carballido, Jonathan E. Rosenberg, Optimal Treatment for Metastatic Bladder Cancer, Current Oncology Reports, 2014, 16, 9

    CrossRef

  7. 7
    Jing Zhang, Lei Miao, Shutao Guo, Yuan Zhang, Lu Zhang, Andrew Satterlee, William Y. Kim, Leaf Huang, Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model, Journal of Controlled Release, 2014, 182, 90

    CrossRef

  8. 8
    Petros D. Grivas, Maha Hussain, Khaled Hafez, Stephanie Daignault-Newton, David Wood, Cheryl T. Lee, Alon Weizer, James E. Montie, Brent Hollenbeck, Jeffrey S. Montgomery, Ajjai Alva, David C. Smith, A Phase II Trial of Neoadjuvant nab-paclitaxel, Carboplatin, and Gemcitabine (ACaG) in Patients With Locally Advanced Carcinoma of the Bladder, Urology, 2013, 82, 1, 111

    CrossRef

  9. 9
    Nobuaki Matsubara, Hirofumi Mukai, Yoichi Naito, Masahiko Nezu, Kuniaki Itoh, Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer, Asia-Pacific Journal of Clinical Oncology, 2013, 9, 4
  10. 10
    Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Shingo Hatakeyama, Hayato Yamamoto, Takahiro Yoneyama, Noritaka Kamimura, Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study, International Journal of Clinical Oncology, 2013, 18, 4, 724

    CrossRef

  11. 11
    Cora N. Sternberg, Joaquim Bellmunt, Guru Sonpavde, Arlene O. Siefker-Radtke, Walter M. Stadler, Dean F. Bajorin, Robert Dreicer, Daniel J. George, Matthew I. Milowsky, Dan Theodorescu, David J. Vaughn, Matthew D. Galsky, Mark S. Soloway, David I. Quinn, ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings, European Urology, 2013, 63, 1, 58

    CrossRef

  12. 12
    Earle F. Burgess, Individualized management of advanced bladder cancer: Where do we stand?, Urologic Oncology: Seminars and Original Investigations, 2013,

    CrossRef

  13. 13
    Itay A. Sternberg, Guido Dalbagni, Ling Y. Chen, Sherri M. Donat, Bernard H. Bochner, Harry W. Herr, Intravesical Gemcitabine for High Risk, Nonmuscle Invasive Bladder Cancer after Bacillus Calmette-Guérin Treatment Failure, The Journal of Urology, 2013, 190, 5, 1686

    CrossRef

  14. 14
    Kiranpreet K. Khurana, Jorge A. Garcia, Rahul D. Tendulkar, Andrew J. Stephenson, Multidisciplinary Management of Patients with Localized Bladder Cancer, Surgical Oncology Clinics of North America, 2013, 22, 2, 357

    CrossRef

  15. 15
    Christopher M Tully, Gopa Iyer, Dean F Bajorin, Neoadjuvant chemotherapy in bladder cancer, Clinical Investigation, 2013, 3, 10, 991

    CrossRef

  16. 16
    Damien Pouessel, Pierre Mongiat-Artus, Stéphane Culine, Neoadjuvant chemotherapy in muscle-invasive bladder cancer: Ready for prime time?, Critical Reviews in Oncology/Hematology, 2013, 85, 3, 288

    CrossRef

  17. 17
    Adrian S. Fairey, Siamak Daneshmand, David Quinn, Tanya Dorff, Ryan Dorin, Gary Lieskovsky, Anne Schuckman, Jie Cai, Gus Miranda, Eila C. Skinner, Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California, Urologic Oncology: Seminars and Original Investigations, 2013, 31, 8, 1737

    CrossRef

  18. 18
    K. Iwasaki, W. Obara, Y. Kato, R. Takata, S. Tanji, T. Fujioka, Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer, Japanese Journal of Clinical Oncology, 2013, 43, 2, 193

    CrossRef

  19. 19
    C.-H. Ohlmann, M. Santis, Neoadjuvante, induktive oder adjuvante Chemotherapie des Blasenkarzinoms, Der Urologe, 2013, 52, 11, 1534

    CrossRef

  20. 20
    Jennifer J. Ahn, James M. McKiernan, New Agents for Bacillus Calmette-Guérin–Refractory Bladder Cancer, Urologic Clinics of North America, 2013, 40, 2, 219

    CrossRef

  21. 21
    Franklin C. Lee, William Harris, Heather H. Cheng, Jaideep Shenoi, Song Zhao, Junfeng Wang, Thomas Champion, Jason Izard, John L. Gore, Michael Porter, Evan Y. Yu, Jonathan L. Wright, Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer, Advances in Urology, 2013, 2013, 1

    CrossRef

  22. 22
    Bertram E. Yuh, Nora Ruel, Timothy G. Wilson, Nicholas Vogelzang, Sumanta K. Pal, Pooled Analysis of Clinical Outcomes with Neoadjuvant Cisplatin and Gemcitabine Chemotherapy for Muscle Invasive Bladder Cancer, The Journal of Urology, 2013, 189, 5, 1682

    CrossRef

  23. 23
    Jeffrey M Holzbeierlein, Michael E Aberger, The treatment of muscle-invasive bladder cancer in elderly patients, Aging Health, 2013, 9, 5, 529

    CrossRef

  24. You have free access to this content24
    Mun Sem Liew, Arun Azad, Ali Tafreshi, Renu Eapen, Damien Bolton, Ian D. Davis, Shomik Sengupta, USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer, BJU International, 2013, 112,
  25. 25
    Joshua J. Meeks, Joaquim Bellmunt, Bernard H. Bochner, Noel W. Clarke, Siamak Daneshmand, Matthew D. Galsky, Noah M. Hahn, Seth P. Lerner, Malcolm Mason, Thomas Powles, Cora N. Sternberg, Guru Sonpavde, A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer, European Urology, 2012, 62, 3, 523

    CrossRef

  26. 26
    Christopher Blick, Peter Hall, Thinn Pwint, Faisal Al-Terkait, Jeremy Crew, Thomas Powles, Valentine Macaulay, Nicholas Munro, David Douglas, Neviana Kilbey, Andrew Protheroe, John D. Chester, Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder, Cancer, 2012, 118, 16
  27. 27
    N. Houédé, P. Beuzeboc, S. Culine, M. Soulié, C. Pfister, Chimiothérapie périopératoire des carcinomes urothéliaux infiltrants de vessie de stade localisé. Une revue de la littérature du groupe vessie du CC-AFU, Progrès en Urologie, 2012, 22, 3, 139

    CrossRef

  28. 28
    Ajjai S. Alva, Christopher T. Tallman, Chang He, Maha H. Hussain, Khaled Hafez, James E. Montie, David C. Smith, Alon Z. Weizer, David Wood, Cheryl T. Lee, Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer, Cancer, 2012, 118, 1
  29. 29
    C.-H. Ohlmann, A. Lorch, M. Stöckle, J. Beyer, Lokal fortgeschrittenes Blasenkarzinom, Der Onkologe, 2012, 18, 11, 994

    CrossRef

  30. 30
    Guru Sonpavde, Cora N. Sternberg, Neoadjuvant Chemotherapy for Invasive Bladder Cancer, Current Urology Reports, 2012, 13, 2, 136

    CrossRef

  31. 31
    Emil Scosyrev, Edward M. Messing, Edwin van Wijngaarden, Derick R. Peterson, Deepak Sahasrabudhe, Dragan Golijanin, Susan G. Fisher, Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder, Cancer, 2012, 118, 1
  32. 32
    Mun Sem LIEW, George AU-YEUNG, Ian D. DAVIS, Pathological responses to gemcitabine/platinum-based neoadjuvant chemotherapy for muscle-invasive urothelial cancer, Asia-Pacific Journal of Clinical Oncology, 2012, 8, 1
  33. You have free access to this content33
    Norikata Takada, Takashige Abe, Nobuo Shinohara, Ataru Sazawa, Satoru Maruyama, Yuichiro Shinno, Soshu Sato, Kimiyoshi Mitsuhashi, Takuya Sato, Keiji Sugishita, Shinji Kamota, Takanori Yamashita, Junji Ishizaki, Takaya Hioka, Gaku Mouri, Takenori Ono, Naoto Miyajima, Takanori Sakuta, Tango Mochizuki, Toshiki Aoyagi, Hidenori Katano, Tomoshige Akino, Kazushi Hirakawa, Keita Minami, Akira Kumagai, Toshimori Seki, Masaki Togashi, Katsuya Nonomura, Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan, BJU International, 2012, 110, 11b
  34. 34
    Andrea B. Apolo, Herbert Barton Grossman, Dean Bajorin, Gary Steinberg, Ashish M. Kamat, Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: Summary of session at the Society of Urologic Oncology annual meeting, Urologic Oncology: Seminars and Original Investigations, 2012, 30, 6, 772

    CrossRef

  35. 35
    Guru Sonpavde, Shahrokh F. Shariat, Preoperative chemotherapy for bladder cancer, Cancer, 2012, 118, 1
  36. 36
    Eduardo Solsona, Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastin Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial, European Urology, 2012, 61, 5, 1063

    CrossRef

  37. 37
    Olga Yeshchina, Gina M. Badalato, Matthew S. Wosnitzer, Gregory Hruby, Arindam RoyChoudhury, Mitchell C. Benson, Daniel P. Petrylak, James M. McKiernan, Relative Efficacy of Perioperative Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Adriamycin, and Cisplatin in the Management of Locally Advanced Urothelial Carcinoma of the Bladder, Urology, 2012, 79, 2, 384

    CrossRef

  38. 38
    Sumanta K. Pal, Nora H. Ruel, Timothy G. Wilson, Bertram E. Yuh, Retrospective Analysis of Clinical Outcomes With Neoadjuvant Cisplatin-Based Regimens for Muscle-Invasive Bladder Cancer, Clinical Genitourinary Cancer, 2012, 10, 4, 246

    CrossRef

  39. 39
    Carmel Pezaro, Mun Sem Liew, Ian D Davis, Urothelial cancers: using biology to improve outcomes, Expert Review of Anticancer Therapy, 2012, 12, 1, 87

    CrossRef

  40. 40
    Seth P. Lerner, Cora N. Sternberg, Campbell-Walsh Urology, 2012,

    CrossRef

  41. 41
    Todd M Morgan, Kirk A Keegan, Peter E Clark, Bladder cancer, Current Opinion in Oncology, 2011, 23, 3, 275

    CrossRef

  42. 42
    Pirus Ghadjar, Fiona C. Burkhard, Oliver Gautschi, George N. Thalmann, Urs E. Studer, Induction chemotherapy for unresectable urothelial carcinoma of the bladder, BJU International, 2011, 107, 6
  43. 43
    Andrew H. Feifer, Jennifer M. Taylor, Tatum V. Tarin, Harry W. Herr, Maximizing Cure for Muscle-Invasive Bladder Cancer: Integration of Surgery and Chemotherapy, European Urology, 2011, 59, 6, 978

    CrossRef

  44. 44
    Nikhil Vasdev, Matthew B.K. Shaw, Andrew C. Thorpe, Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer, Current Urology, 2011, 5, 2, 57

    CrossRef

  45. 45
    G. Kaneko, E. Kikuchi, K. Matsumoto, J. Obata, S. Nakamura, A. Miyajima, M. Oya, Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer, Japanese Journal of Clinical Oncology, 2011, 41, 7, 908

    CrossRef

  46. 46
    Matthew G. Kaag, Matthew I. Milowsky, Guido Dalbagni, R. Houston Thompson, Darren Katz, Victor E. Reuter, Harry W. Herr, Dean Bajorin, Bernard H. Bochner, Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy, BJU International, 2011, 108, 8b
  47. 47
    Tatsuo Gondo, Makoto Ohori, Riu Hamada, Ayako Tanaka, Naoya Satake, Hisashi Takeuchi, Jun Nakashima, Tadashi Hatano, Masaaki Tachibana, The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen, International Journal of Clinical Oncology, 2011, 16, 4, 345

    CrossRef

  48. 48
    Carrie Costantini, Frederick Millard, Update on Chemotherapy in the Treatment of Urothelial Carcinoma, The Scientific World JOURNAL, 2011, 11, 1981

    CrossRef

  49. 49
    Todd M Morgan, Peter E Clark, Bladder cancer, Current Opinion in Oncology, 2010, 22, 3, 242

    CrossRef

  50. 50
    Jacques Gilloteaux, James M. Jamison, Deborah R. Neal, Marios Loukas, Theresa Doberzstyn, Jack L. Summers, Cell Damage and Death by Autoschizis in Human Bladder (RT4) Carcinoma Cells Resulting from Treatment with Ascorbate and Menadione, Ultrastructural Pathology, 2010, 34, 3, 140

    CrossRef

  51. 51
    Marko Babjuk, Current Value of Neoadjuvant Chemotherapy Prior to Cystectomy, European Urology Supplements, 2010, 9, 3, 424

    CrossRef

  52. 52
    Guru Sonpavde, Cora N. Sternberg, Neoadjuvant systemic therapy for urological malignancies, BJU International, 2010, 106, 1
  53. 53
    Paolo Puppo, Giario Conti, Francesco Francesca, Alberto Mandressi, Angelo Naselli, New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classification, BJU International, 2010, 106, 2
  54. 54
    P. Mongiat-Artus, C. Pfister, C. Théodore, R. De Crevoisier, J. Guillotreau, Tumeur urothéliale de vessie chez le patient « fragile », Progrès en Urologie, 2010, 20, S54

    CrossRef

  55. 55
    Fred Saad, James A. Eastham, Zoledronic Acid Use in Patients With Bone Metastases From Renal Cell Carcinoma or Bladder Cancer, Seminars in Oncology, 2010, 37, S38

    CrossRef

  56. 56
    Faysal A Yafi, Wassim Kassouf, Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?, Expert Review of Anticancer Therapy, 2009, 9, 6, 747

    CrossRef

  57. 57
    Rafael Sánchez-Salas, Gemma I. Duque Ruiz, John Watson, Eugenio Rocha, Eric Barret, Xavier Cathelineau, Francois Rozet, Marc Galiano, Guy Vallancien, La integración de la cirugía y el tratamiento quimioterápico en el cáncer de vejiga infiltrante, Actas Urológicas Españolas, 2009, 33, 10, 1062

    CrossRef

  58. 58
    Christopher J. Weight, Jorge A. Garcia, Donna E. Hansel, Amr F. Fergany, Steven C. Campbell, Michael C. Gong, J. Stephen Jones, Eric A. Klein, Robert Dreicer, Andrew J. Stephenson, Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder, Cancer, 2009, 115, 4
  59. 59
    Neeraj Agarwal, Maha Hussain, Management of Bladder Cancer, Drugs, 2009, 69, 9, 1173

    CrossRef

  60. 60
    Harry W. Herr, Neoadjuvant Chemotherapy: A New Treatment Paradigm for Muscle-Invasive Bladder Cancer, European Urology, 2009, 55, 2, 303

    CrossRef

  61. 61
    Ralph W. deVere White, Mark H. Katz, Gary D. Steinberg, Opposing Views, The Journal of Urology, 2009, 181, 5, 1994

    CrossRef

  62. 62
    Cora N. Sternberg, Fabio Calabrò, Rebuttal from Authors re: Harry W. Herr. Neoadjuvant Chemotherapy: A New Treatment Paradigm for Muscle-Invasive Bladder Cancer. Eur Urol 2009;55:303–5, European Urology, 2009, 55, 2, 305

    CrossRef

  63. 63
    Matthew E. Nielsen, Neoadjuvant gemcitabine and cisplatin: Another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer, Cancer, 2008, 113, 9